ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

A Phase I Clinical Study and In Vivo Findings with PT-112, a Novel Immunogenic Cell Death-Inducing Small Molecule, in Relapsed or Refractory Multiple Myeloma.

Taxiarchis Kourelis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.